Straumann Holding (STMN) Stock Overview
Provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
STMN Community Fair Values
See what 28 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Straumann Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 83.62 |
| 52 Week High | CHF 114.25 |
| 52 Week Low | CHF 73.02 |
| Beta | 1.38 |
| 1 Month Change | -6.26% |
| 3 Month Change | -14.15% |
| 1 Year Change | -25.87% |
| 3 Year Change | -40.57% |
| 5 Year Change | -38.78% |
| Change since IPO | 3,872.45% |
Recent News & Updates
STMN: Higher Future P/E Assumptions Will Support Confidence In Execution Potential
Straumann's updated analyst price target holds around CHF 123, with recent small CHF 1 to CHF 3 adjustments from different banks reflecting analysts' mixed views on future growth, profit margins, and the appropriate P/E level for the shares. Analyst Commentary Recent Street research shows a mix of views on Straumann, with price targets clustering around CHF 79 to CHF 123 and opinions split on whether the current P/E is justified.STMN: Lower-End CHF 80 Fair Value Will Likely Cap Upside Potential
The updated analyst price target for Straumann Holding edges higher to CHF 80, a CHF 1 change that reflects recent Street research in which analysts have fine tuned assumptions on discount rates, revenue growth and profit margins while incorporating mixed price target moves across firms. Analyst Commentary Recent Street research on Straumann Holding highlights a split in sentiment, with some firms trimming price targets while others make smaller upward adjustments.Recent updates
Shareholder Returns
| STMN | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | -1.3% | -0.2% | 0.4% |
| 1Y | -25.9% | -30.4% | 6.1% |
Return vs Industry: STMN exceeded the Swiss Medical Equipment industry which returned -30.4% over the past year.
Return vs Market: STMN underperformed the Swiss Market which returned 6.1% over the past year.
Price Volatility
| STMN volatility | |
|---|---|
| STMN Average Weekly Movement | 4.8% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in CH Market | 8.2% |
| 10% least volatile stocks in CH Market | 2.5% |
Stable Share Price: STMN has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: STMN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 11,570 | Guillaume Daniellot | www.straumann.com |
Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss.
Straumann Holding AG Fundamentals Summary
| STMN fundamental statistics | |
|---|---|
| Market cap | CHF 13.32b |
| Earnings (TTM) | CHF 356.71m |
| Revenue (TTM) | CHF 2.61b |
Is STMN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STMN income statement (TTM) | |
|---|---|
| Revenue | CHF 2.61b |
| Cost of Revenue | CHF 779.08m |
| Gross Profit | CHF 1.83b |
| Other Expenses | CHF 1.47b |
| Earnings | CHF 356.71m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Aug 19, 2026
| Earnings per share (EPS) | 2.24 |
| Gross Margin | 70.10% |
| Net Profit Margin | 13.69% |
| Debt/Equity Ratio | 11.5% |
How did STMN perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/15 18:14 |
| End of Day Share Price | 2026/05/15 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Straumann Holding AG is covered by 35 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Bate | Barclays |
| Hassan Al-Wakeel | Barclays |
| Victoria Lambert | Berenberg |